{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:32:25Z","timestamp":1755797545892,"version":"3.44.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"am","delay-in-days":252,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI140287"],"award-info":[{"award-number":["R01AI140287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diagmicrobio.2025.116991","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T22:30:14Z","timestamp":1751581814000},"page":"116991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii"],"prefix":"10.1016","volume":"113","author":[{"given":"Brianna M.","family":"Eales","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James E.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazanin","family":"Pouya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole S.","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo P.","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Truc T.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7071-5376","authenticated-orcid":false,"given":"Vincent H.","family":"Tam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.diagmicrobio.2025.116991_bib0001","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/533452","article-title":"Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE","volume":"197","author":"Rice","year":"2008","journal-title":"J Infect Dis"},{"issue":"2-3","key":"10.1016\/j.diagmicrobio.2025.116991_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-6445(03)00055-X","article-title":"Rodriguez-Quinones F. Bacterial iron homeostasis","volume":"27","author":"Andrews","year":"2003","journal-title":"FEMS Microbiol Rev"},{"issue":"15","key":"10.1016\/j.diagmicrobio.2025.116991_bib0003","doi-asserted-by":"crossref","first-page":"R642","DOI":"10.1016\/j.cub.2013.05.033","article-title":"The essential nature of iron usage and regulation","volume":"23","author":"Kaplan","year":"2013","journal-title":"Curr Biol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116991_bib0004","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/1757177415622693","article-title":"Recent emergence of carbapenem-resistant organisms in a low prevalence UK setting in London","volume":"17","author":"Hughes","year":"2016","journal-title":"J Infect Prev"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116991_bib0005","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1309\/LMF28S2GIMXNWHMM","article-title":"The molecular biology of human iron metabolism","volume":"45","author":"Winter","year":"2014","journal-title":"Lab Med"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116991_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0034-1398388","article-title":"Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options","volume":"36","author":"Doi","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.116991_bib0007","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/cid\/ciab1013","article-title":"Infectious Diseases Society of America guidance on the treatment of AmpC beta-lactamase-producing enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia infections","volume":"74","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.116991_bib0008","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nrmicro1789","article-title":"An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii","volume":"5","author":"Dijkshoorn","year":"2007","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.116991_bib0009","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s11033-020-05389-4","article-title":"Genetic mechanisms of antibiotic resistance and virulence in Acinetobacter baumannii: background, challenges and future prospects","volume":"47","author":"Chakravarty","year":"2020","journal-title":"Mol Biol Rep"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116991_bib0010","article-title":"Systematic review of antimicrobial combination options for pandrug-resistant Acinetobacter baumannii","volume":"10","author":"Karakonstantis","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116991_bib0011","first-page":"164","article-title":"Review on iron and its importance for human health","volume":"19","author":"Abbaspour","year":"2014","journal-title":"J Res Med Sci"},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2023.105992","article-title":"Characterization of the enzymatic and multifunctional properties of Acinetobacter baumannii erythrose-4-phosphate dehydrogenase (E4PDH)","volume":"175","author":"Nimma","year":"2023","journal-title":"Microb Pathog"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116991_bib0013","doi-asserted-by":"crossref","first-page":"ovad019","DOI":"10.1093\/lambio\/ovad019","article-title":"Growth of Acinetobacter baumannii impacted by iron chelation","volume":"76","author":"Eales","year":"2023","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0014","unstructured":"Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing: twenty-first informational supplement M100-S21 2015 USA CLSI. 2020."},{"issue":"15","key":"10.1016\/j.diagmicrobio.2025.116991_bib0015","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.116991_bib0016","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/cmb.2012.0021","article-title":"SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing","volume":"19","author":"Bankevich","year":"2012","journal-title":"J Comput Biol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116991_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91456-0","article-title":"AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence","volume":"11","author":"Feldgarden","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116991_bib0018","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-024-03198-7","article-title":"Rapid and sensitive detection of genome contamination at scale with FCS-GX","volume":"25","author":"Astashyn","year":"2024","journal-title":"Genome Biol"},{"year":"2016","series-title":"ABRicate: mass screening of contigs for antibiotic resistance genes","author":"Seemann","key":"10.1016\/j.diagmicrobio.2025.116991_bib0019"},{"issue":"D1","key":"10.1016\/j.diagmicrobio.2025.116991_bib0020","doi-asserted-by":"crossref","first-page":"D912","DOI":"10.1093\/nar\/gkab1107","article-title":"VFDB 2022: a general classification scheme for bacterial virulence factors","volume":"50","author":"Liu","year":"2022","journal-title":"Nucl Acid Res"},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.compchemeng.2021.107617","article-title":"Discerning in vitro pharmacodynamics from OD measurements: A model-based approach","volume":"158","author":"Kesisoglou","year":"2022","journal-title":"Comput Chem Eng"},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0022","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jgar.2024.06.011","article-title":"In vitro evaluation of using ceftazidime\/avibactam against carbapenem-resistant Acinetobacter baumannii","volume":"38","author":"Pouya","year":"2024","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.116991_bib0023","article-title":"Pharmacokinetics and pharmacodynamics of minocycline against Acinetobacter baumannii in a neutropenic murine pneumonia model","volume":"61","author":"Zhou","year":"2017","journal-title":"Antimicrob Agent Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2025.116991_bib0024","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1086\/651024","article-title":"Quantitative assessment of combination antimicrobial therapy against multidrug-resistant bacteria in a murine pneumonia model","volume":"201","author":"Yuan","year":"2010","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.116991_bib0025","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1128\/AAC.00508-11","article-title":"Quantitative impact of neutrophils on bacterial clearance in a murine pneumonia model","volume":"55","author":"Guo","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0026","unstructured":"Ceftazidime [package insert]. Buena, NJ: Teligent Pharma, Inc 2018."},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0027","article-title":"ADAPT 5 user\u2019s Guide: pharmacokinetic\/pharmacodynamic systems analysis software","author":"D'Argenio","year":"2009","journal-title":"Biomed Simulat Resour"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2025.116991_bib0028","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/jac\/dkx001","article-title":"Determining beta-lactam exposure threshold to suppress resistance development in gram-negative bacteria","volume":"72","author":"Tam","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2025.116991_bib0029","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/jac\/dkaa412","article-title":"Optimizing pharmacokinetics\/pharmacodynamics of beta-lactam\/beta-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria","volume":"76","author":"Tam","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0030","unstructured":"Antibiotic resistance threats in the United States, 2019. 2019, https:\/\/stacks.cdc.gov\/view\/cdc\/82532."},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0031","unstructured":"WHO. Antimicrobial resistance; 2021. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. [Accessed 21 March 2021]."},{"key":"10.1016\/j.diagmicrobio.2025.116991_bib0032","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mib.2019.10.008","article-title":"Antibiotics: past, present and future","volume":"51","author":"Hutchings","year":"2019","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116991_bib0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/antibiotics9030119","article-title":"Insights into Acinetobacter baumannii: A review of microbiological, virulence, and resistance traits in a threatening nosocomial pathogen","volume":"9","author":"Ayoub Moubareck","year":"2020","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2025.116991_bib0034","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrmicro.2017.148","article-title":"Uncovering the mechanisms of Acinetobacter baumannii virulence","volume":"16","author":"Harding","year":"2018","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2025.116991_bib0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1574-695X.2011.00926.x","article-title":"Characterization of the Acinetobacter baumannii growth phase-dependent and serum responsive transcriptomes","volume":"64","author":"Jacobs","year":"2012","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2025.116991_bib0036","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1128\/AAC.00778-12","article-title":"In vitro and in vivo biological activities of iron chelators and gallium nitrate against Acinetobacter baumannii","volume":"56","author":"de Leseleuc","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"23","key":"10.1016\/j.diagmicrobio.2025.116991_bib0037","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1128\/JB.00758-15","article-title":"Escherichia coli free radical-based killing mechanism driven by a unique combination of iron restriction and certain antibiotics","volume":"197","author":"Ma","year":"2015","journal-title":"J Bacteriol"},{"issue":"11","key":"10.1016\/j.diagmicrobio.2025.116991_bib0038","doi-asserted-by":"crossref","first-page":"6913","DOI":"10.1128\/AAC.03267-14","article-title":"In vivo efficacy of humanized exposures of Ceftazidime-Avibactam in comparison with Ceftazidime against contemporary Enterobacteriaceae isolates","volume":"58","author":"MacVane","year":"2014","journal-title":"Antimicrob Agent Chemother"},{"issue":"12","key":"10.1016\/j.diagmicrobio.2025.116991_bib0039","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1128\/AAC.00851-12","article-title":"Comparative in vitro and in vivo efficacies of human simulated doses of ceftazidime and ceftazidime-avibactam against Pseudomonas aeruginosa","volume":"56","author":"Crandon","year":"2012","journal-title":"Antimicrob Agent Chemother"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325003141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889325003141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:38:27Z","timestamp":1755553107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889325003141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0732889325003141"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116991","relation":{},"ISSN":["0732-8893"],"issn-type":[{"type":"print","value":"0732-8893"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of iron limitation on in vitro and in vivo activity of ceftazidime against A. baumannii","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2025.116991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116991"}}